FathomX

fathomx.co

FathomX is a MedTech AI spin-off from the National University of Singapore and National University Health System that aims to deploy clinician-friendly solutions to enhancing the existing workflow. Our first project targets public health and aims to enhance breast cancer screening with AI by significantly reducing false positive rates by 80% and enhancing the clinical workflow by cutting down the clinician number by 50%. These are findings that have been published in the prestigious JAMA Open Network and AAAI Workshop. The company works closely with global solutions provider HP Enterprise to develop a range of technologies in the field of medical imaging and has integrated our AI engines into a technical infrastructure that is scalable, customizable, and already tested out in various hospitals and clinics.